Breckenridge Pharmaceutical, Inc. has announced that the FDA has granted final approval for the company’s Abbreviated New Drug Application (ANDA) for Terbinafine HCl Tablets, 250mg. Terbinafine HCl Tablets are AB rated to Lamisil®, a brand product marketed by Novartis. Breckenridge plans to launch the product this summer.